Tapewire

Nasdaq · USD

BTAI

BioXcel Therapeutics, Inc.

Export transactions ↓
Tapewire entity
8380
SEC CIK
0001720893
Parsed reports
276

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202604
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 23, 2019 Filed May 29, 2019 01:01 UTC GrantStock Option (Right to Buy) · Derivative 14,700 $0.00 Strike: $10.04 $0.00
Disclosure

SEC source: 0001104659-19-032143 · a4.xml · derivative · entry 1

Laumas Sandeep · CIK 0001721664 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,700

Underlying: Common Stock · 14,700 shares

Expires 2029-05-23

F1 · derivative.exercise_date: The option will vest in full and become exercisable on the first anniversary of the grant date.

Read SEC document
May 23, 2019 Filed Jun 19, 2019 21:07 UTC OtherStock Option (Right to Buy) · Derivative 4,700 $0.00 Strike: $10.04 $0.00
Disclosure

SEC source: 0001104659-19-036496 · a4.xml · derivative · entry 2

Votruba Michal · CIK 0001653967 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,700 shares

Expires 2029-05-23

F1 · kind: The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund ("RSJ") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person does not beneficially own any of the securities reported herein.

F2 · derivative.exercise_date: The option will vest in full and become exercisable on the first anniversary of the grant date.

Read SEC document
May 23, 2019 Filed Jun 19, 2019 21:07 UTC GrantStock Option (Right to Buy) · Derivative 4,700 $0.00 Strike: $10.04 $0.00
Disclosure

SEC source: 0001104659-19-036496 · a4.xml · derivative · entry 1

Votruba Michal · CIK 0001653967 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,700

Underlying: Common Stock · 4,700 shares

Expires 2029-05-23

F1 · kind: The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund ("RSJ") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person does not beneficially own any of the securities reported herein.

F2 · derivative.exercise_date: The option will vest in full and become exercisable on the first anniversary of the grant date.

Read SEC document
April 01, 2019 Filed Feb 16, 2021 22:26 UTC GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-024409 · tm216714-1_4seq1.xml · nonDerivative · entry 2

Nandabalan Krishnan · CIK 0001733387 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 1,000

F1 · ownership.nature: Shares held by The Sunanda Family Trust.

Read SEC document
April 01, 2019 Filed Feb 16, 2021 22:26 UTC GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-024409 · tm216714-1_4seq1.xml · nonDerivative · entry 1

Nandabalan Krishnan · CIK 0001733387 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
March 07, 2019 Filed Mar 18, 2019 17:38 UTC Disposition to issuerStock Options (Right to Buy) · Derivative 10,000 $7.91 Strike: $7.91 $79,100.00
Disclosure

SEC source: 0001104659-19-015669 · a4.xml · derivative · entry 1

Votruba Michal · CIK 0001653967 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2029-03-07

F1 · derivative.exercise_date: The shares underlying this stock option vest as follows: one-third on each of 3/7/2020, 3/7/2021 and 3/7/2022, subject to the Reporting Person's continuous service to the Issuer through such dates.

F2 · derivative.underlying_shares: The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. ("RSJ") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person is serving on the Board of the Issuer with the permission of RSJ.

Read SEC document
December 14, 2018 Filed Dec 14, 2018 21:30 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 100 $4.50 $450.00
Disclosure

SEC source: 0001104659-18-073106 · a4.xml · nonDerivative · entry 5

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Read SEC document
December 14, 2018 Filed Dec 14, 2018 21:30 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 400 $4.49 $1,796.00
Disclosure

SEC source: 0001104659-18-073106 · a4.xml · nonDerivative · entry 4

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,900

Read SEC document
December 14, 2018 Filed Dec 14, 2018 21:30 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 500 $4.48 $2,240.00
Disclosure

SEC source: 0001104659-18-073106 · a4.xml · nonDerivative · entry 3

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,500

Read SEC document
December 14, 2018 Filed Dec 14, 2018 21:30 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 200 $4.32 $864.00
Disclosure

SEC source: 0001104659-18-073106 · a4.xml · nonDerivative · entry 2

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

Read SEC document
December 14, 2018 Filed Dec 14, 2018 21:30 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 800 $4.27 $3,416.00
Disclosure

SEC source: 0001104659-18-073106 · a4.xml · nonDerivative · entry 1

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,800

Read SEC document
December 07, 2018 Filed Dec 7, 2018 17:50 UTC PurchaseCommon Stock 6,905 $5.01 $34,594.05
Disclosure

SEC source: 0001104659-18-071881 · a4.xml · nonDerivative · entry 4

MUELLER PETER · CIK 0001256126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,320

Read SEC document
December 07, 2018 Filed Dec 7, 2018 17:50 UTC PurchaseCommon Stock 495 $5.00 $2,475.00
Disclosure

SEC source: 0001104659-18-071881 · a4.xml · nonDerivative · entry 3

MUELLER PETER · CIK 0001256126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,415

Read SEC document
December 06, 2018 Filed Dec 7, 2018 17:50 UTC PurchaseCommon Stock 100 $5.01 $501.00
Disclosure

SEC source: 0001104659-18-071881 · a4.xml · nonDerivative · entry 2

MUELLER PETER · CIK 0001256126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,920

Read SEC document
December 06, 2018 Filed Dec 7, 2018 17:50 UTC PurchaseCommon Stock 1,295 $5.00 $6,475.00
Disclosure

SEC source: 0001104659-18-071881 · a4.xml · nonDerivative · entry 1

MUELLER PETER · CIK 0001256126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,820

Read SEC document
December 04, 2018 Filed Dec 4, 2018 22:05 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 500 $5.15 $2,575.00
Disclosure

SEC source: 0001104659-18-071405 · a4.xml · nonDerivative · entry 2

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Read SEC document
December 04, 2018 Filed Dec 4, 2018 22:05 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 500 $5.09 $2,545.00
Disclosure

SEC source: 0001104659-18-071405 · a4.xml · nonDerivative · entry 1

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Read SEC document
December 04, 2018 Filed Dec 6, 2018 17:34 UTC PurchaseCommon Stock 2,062 $5.15 $10,619.30
Disclosure

SEC source: 0001104659-18-071741 · a4.xml · nonDerivative · entry 5

MUELLER PETER · CIK 0001256126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,525

Read SEC document
December 04, 2018 Filed Dec 6, 2018 17:34 UTC PurchaseCommon Stock 200 $5.13 $1,026.00
Disclosure

SEC source: 0001104659-18-071741 · a4.xml · nonDerivative · entry 4

MUELLER PETER · CIK 0001256126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,463

Read SEC document
December 04, 2018 Filed Dec 6, 2018 17:34 UTC PurchaseCommon Stock 344 $5.12 $1,761.28
Disclosure

SEC source: 0001104659-18-071741 · a4.xml · nonDerivative · entry 3

MUELLER PETER · CIK 0001256126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,263

Read SEC document
December 04, 2018 Filed Dec 6, 2018 17:34 UTC PurchaseCommon Stock 325 $5.11 $1,660.75
Disclosure

SEC source: 0001104659-18-071741 · a4.xml · nonDerivative · entry 2

MUELLER PETER · CIK 0001256126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,919

Read SEC document
December 04, 2018 Filed Dec 6, 2018 17:34 UTC PurchaseCommon Stock 1,076 $5.09 $5,476.84
Disclosure

SEC source: 0001104659-18-071741 · a4.xml · nonDerivative · entry 1

MUELLER PETER · CIK 0001256126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,594

Read SEC document
December 04, 2018 Filed Dec 6, 2018 11:04 UTC
Yocca FrankChief Scientific Officer
PurchaseCommon Stock 450 $5.20 $2,338.79
Disclosure

SEC source: 0001104659-18-071465 · a4.xml · nonDerivative · entry 2

Yocca Frank · CIK 0001733272 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,850

Read SEC document
December 03, 2018 Filed Dec 4, 2018 15:22 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 500 $5.20 $2,600.00
Disclosure

SEC source: 0001104659-18-071220 · a4.xml · nonDerivative · entry 5

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Read SEC document
December 03, 2018 Filed Dec 4, 2018 15:22 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 100 $5.18 $518.00
Disclosure

SEC source: 0001104659-18-071220 · a4.xml · nonDerivative · entry 4

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Read SEC document
December 03, 2018 Filed Dec 4, 2018 15:22 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 100 $5.14 $514.00
Disclosure

SEC source: 0001104659-18-071220 · a4.xml · nonDerivative · entry 3

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,400

Read SEC document
December 03, 2018 Filed Dec 4, 2018 15:22 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 100 $5.13 $513.00
Disclosure

SEC source: 0001104659-18-071220 · a4.xml · nonDerivative · entry 2

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,300

Read SEC document
December 03, 2018 Filed Dec 4, 2018 15:22 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 200 $5.10 $1,020.00
Disclosure

SEC source: 0001104659-18-071220 · a4.xml · nonDerivative · entry 1

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,200

Read SEC document
December 03, 2018 Filed Dec 4, 2018 14:49 UTC
Steinhart Richard IChief Financial Officer
PurchaseCommon Stock 500 $5.20 $2,599.95
Disclosure

SEC source: 0001104659-18-071215 · a4.xml · nonDerivative · entry 1

Steinhart Richard I · CIK 0001293789 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Read SEC document
December 03, 2018 Filed Dec 6, 2018 11:04 UTC
Yocca FrankChief Scientific Officer
PurchaseCommon Stock 450 $5.23 $2,353.46
Disclosure

SEC source: 0001104659-18-071465 · a4.xml · nonDerivative · entry 1

Yocca Frank · CIK 0001733272 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,400

Read SEC document
November 30, 2018 Filed Nov 30, 2018 21:10 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 300 $5.20 $1,560.00
Disclosure

SEC source: 0001104659-18-070826 · a4.xml · nonDerivative · entry 4

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Read SEC document
November 30, 2018 Filed Nov 30, 2018 21:10 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 100 $5.17 $517.00
Disclosure

SEC source: 0001104659-18-070826 · a4.xml · nonDerivative · entry 3

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 700

Read SEC document
November 30, 2018 Filed Nov 30, 2018 21:10 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 300 $5.05 $1,515.00
Disclosure

SEC source: 0001104659-18-070826 · a4.xml · nonDerivative · entry 2

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 600

Read SEC document
November 30, 2018 Filed Nov 30, 2018 21:10 UTC
Mehta VimalDirector · CEO, President, Secretary
PurchaseCommon Stock 300 $5.04 $1,512.00
Disclosure

SEC source: 0001104659-18-070826 · a4.xml · nonDerivative · entry 1

Mehta Vimal · CIK 0001733369 · Director · CEO, President, Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300

Read SEC document
November 30, 2018 Filed Nov 30, 2018 22:36 UTC
Steinhart Richard IChief Financial Officer
PurchaseCommon Stock 500 $5.00 $2,500.00
Disclosure

SEC source: 0001104659-18-070876 · a4.xml · nonDerivative · entry 1

Steinhart Richard I · CIK 0001293789 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Read SEC document
November 30, 2018 Filed Nov 30, 2018 22:35 UTC
Yocca FrankChief Scientific Officer
PurchaseCommon Stock 450 $5.20 $2,339.55
Disclosure

SEC source: 0001104659-18-070875 · a4.xml · nonDerivative · entry 1

Yocca Frank · CIK 0001733272 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 950

Read SEC document
November 29, 2018 Filed Nov 30, 2018 19:30 UTC
Steinhart Richard IChief Financial Officer
PurchaseCommon Stock 500 $5.00 $2,500.00
Disclosure

SEC source: 0001104659-18-070793 · a4.xml · nonDerivative · entry 1

Steinhart Richard I · CIK 0001293789 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

Read SEC document
November 29, 2018 Filed Nov 30, 2018 21:17 UTC
Nandabalan KrishnanDirector · 10% owner
PurchaseCommon Stock 1,000 $4.92 $4,915.00
Disclosure

SEC source: 0001104659-18-070832 · a4.xml · nonDerivative · entry 1

Nandabalan Krishnan · CIK 0001733387 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

F1 · ownership.direct: By Krishnan Nandabalan and Suganthi Balasubramanian JTWROS

Read SEC document
November 29, 2018 Filed Nov 30, 2018 19:31 UTC
Yocca FrankChief Scientific Officer
PurchaseCommon Stock 500 $5.02 $2,511.15
Disclosure

SEC source: 0001104659-18-070795 · a4.xml · nonDerivative · entry 1

Yocca Frank · CIK 0001733272 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

Read SEC document
July 02, 2018 Filed Feb 14, 2020 16:25 UTC GiftCommon Stock 90,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-021807 · a4.xml · nonDerivative · entry 2

MUELLER PETER · CIK 0001256126 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Family Trust

Disclosed balance after: 90,000

F2 · ownership.nature: Shares are held by the Peter Mueller 2018 Irrevocable Family Trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trust.

Read SEC document
July 02, 2018 Filed Feb 14, 2020 16:25 UTC GiftCommon Stock 90,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-021807 · a4.xml · nonDerivative · entry 1

MUELLER PETER · CIK 0001256126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,795

F1 · balance_after: Number of shares held following the reported transaction reflects 41,475 shares of common stock that were inadvertently omitted from the reporting person's Form 3 filed on March 7, 2018.

Read SEC document
March 12, 2018 Filed Mar 13, 2018 17:10 UTC
O'Neill VincentChief Medical Officer
GrantStock Options · Derivative 31,047 $0.00 Strike: $11.00 $0.00
Disclosure

SEC source: 0001104659-18-017146 · a4.xml · derivative · entry 1

O'Neill Vincent · CIK 0001672718 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,472

Underlying: Common Stock · 31,047 shares

Expires 2028-03-12

F1 · derivative.exercise_date: The shares underlying this stock option vest as follows: in equal monthly installments over the 48 months following the date of grant, begininning on 4/12/2018.

Read SEC document
March 12, 2018 Filed Mar 13, 2018 21:12 UTC
Steinhart Richard IChief Financial Officer
GrantStock Options · Derivative 32,232 $0.00 Strike: $11.00 $0.00
Disclosure

SEC source: 0001104659-18-017149 · a4.xml · derivative · entry 1

Steinhart Richard I · CIK 0001293789 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,130

Underlying: Common Stock · 32,232 shares

Expires 2028-03-12

F1 · derivative.exercise_date: The shares underlying this stock option vest as follows: 8,058 shares shall vest on March 12, 2019 and the remaining 24,174 shares shall vest monthly over 36 months from March 12, 2019 through March 12, 2022.

Read SEC document
March 12, 2018 Filed Mar 13, 2018 17:12 UTC GrantStock Options · Derivative 37,209 $0.00 Strike: $11.00 $0.00
Disclosure

SEC source: 0001104659-18-017148 · a4.xml · derivative · entry 1

MUELLER PETER · CIK 0001256126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,397

Underlying: Common Stock · 37,209 shares

Expires 2028-03-12

F1 · derivative.exercise_date: The shares underlying this stock option vest as follows: one-third (12,403 shares) on each of 3/12/2019, 3/12/2020 and 3/12/2021.

Read SEC document
March 12, 2018 Filed Mar 13, 2018 21:13 UTC GrantStock Options · Derivative 37,209 $0.00 Strike: $11.00 $0.00
Disclosure

SEC source: 0001104659-18-017151 · a4.xml · derivative · entry 1

Laumas Sandeep · CIK 0001721664 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,188

Underlying: Common Stock · 37,209 shares

Expires 2028-03-12

F1 · derivative.exercise_date: The shares underlying this stock option vest as follows: one-third (12,403 shares) on each of 3/12/2019, 3/12/2020 and 3/12/2021.

Read SEC document
March 12, 2018 Filed Mar 13, 2018 21:11 UTC
Yocca FrankChief Scientific Officer
GrantStock Options · Derivative 36,498 $0.00 Strike: $11.00 $0.00
Disclosure

SEC source: 0001104659-18-017147 · a4.xml · derivative · entry 1

Yocca Frank · CIK 0001733272 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,808

Underlying: Common Stock · 36,498 shares

Expires 2028-03-12

F1 · derivative.exercise_date: The shares underlying this stock option vest as follows: 9,125 shares shall vest on March 12, 2019 and the remaining 27,374 shares shall vest monthly over 36 months from March 12, 2019 through March 12, 2022.

Read SEC document
March 12, 2018 Filed Feb 16, 2021 22:27 UTC
Mehta VimalDirector · CEO, President and Secretary
PurchaseCommon Stock 2,000 $11.00 $22,000.00
Disclosure

SEC source: 0001104659-21-024412 · tm216714-3_4seq1.xml · nonDerivative · entry 1

Mehta Vimal · CIK 0001733369 · Director · CEO, President and Secretary

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 2,000

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.